| BPC-157 | APL-BPC10-2610-05 | Supplier lab | purity | 99.1% | 23 Oct 2026 | View BPC-157 lot APL-BPC10-2610-05 |
| BPC-157 + TB-500 (Wolverine Stack) | APL-BPCTB10-2610-05 | Supplier lab | purity | 98.97% | 23 Oct 2026 | View BPC-157 + TB-500 (Wolverine Stack) lot APL-BPCTB10-2610-05 |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJCIP10-2610-05 | Supplier lab | purity | 99.02% | 23 Oct 2026 | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJCIP10-2610-05 |
| CJC-1295 (No DAC) | APL-CJC10-2610-05 | Supplier lab | purity | 99.21% | 23 Oct 2026 | View CJC-1295 (No DAC) lot APL-CJC10-2610-05 |
| Epitalon | APL-EPI10-2610-03 | Supplier lab | purity | 99.17% | 23 Oct 2026 | View Epitalon lot APL-EPI10-2610-03 |
| GHK-Cu | APL-GHK50-2610-05 | Supplier lab | purity | 99.23% | 23 Oct 2026 | View GHK-Cu lot APL-GHK50-2610-05 |
| Glow Stack | APL-GLOW70-2610-05 | Supplier lab | purity | 99.14% | 23 Oct 2026 | View Glow Stack lot APL-GLOW70-2610-05 |
| Ipamorelin | APL-IPA10-2610-05 | Supplier lab | purity | 99.65% | 23 Oct 2026 | View Ipamorelin lot APL-IPA10-2610-05 |
| Kisspeptin | APL-KISS10-2610-03 | Supplier lab | purity | 99.16% | 23 Oct 2026 | View Kisspeptin lot APL-KISS10-2610-03 |
| KLOW | APL-KLOW80-2610-05 | Supplier lab | purity | 99.45% | 23 Oct 2026 | View KLOW lot APL-KLOW80-2610-05 |
| KPV | APL-KPV10-2610-05 | Supplier lab | purity | 99.8% | 23 Oct 2026 | View KPV lot APL-KPV10-2610-05 |
| MOTS-C | APL-MOTS5-2610-05 | Supplier lab | purity | 98.9% | 23 Oct 2026 | View MOTS-C lot APL-MOTS5-2610-05 |
| NAD+ | APL-NAD500-2610-05 | Supplier lab | purity | 99.35% | 23 Oct 2026 | View NAD+ lot APL-NAD500-2610-05 |
| Retatrutide | APL-RETA5-2610-05 | Supplier lab | purity | 99.27% | 23 Oct 2026 | View Retatrutide lot APL-RETA5-2610-05 |
| Selank | APL-SEL10-2610-05 | Supplier lab | purity | 99.69% | 23 Oct 2026 | View Selank lot APL-SEL10-2610-05 |
| Semax | APL-SEM10-2610-05 | Supplier lab | purity | 99.49% | 23 Oct 2026 | View Semax lot APL-SEM10-2610-05 |
| SS-31 (Elamipretide) | APL-SS3110-2610-03 | Supplier lab | purity | 98.94% | 23 Oct 2026 | View SS-31 (Elamipretide) lot APL-SS3110-2610-03 |
| TB-500 | APL-TB10-2610-05 | Supplier lab | purity | 98.65% | 23 Oct 2026 | View TB-500 lot APL-TB10-2610-05 |
| Tesamorelin | APL-TES10-2610-05 | Supplier lab | purity | 98.7% | 23 Oct 2026 | View Tesamorelin lot APL-TES10-2610-05 |
| BPC-157 | APL-BPC10-2609-04 | Supplier lab | purity | 99.11% | 19 Sept 2026 | View BPC-157 lot APL-BPC10-2609-04 |
| BPC-157 + TB-500 (Wolverine Stack) | APL-BPCTB10-2609-04 | Supplier lab | purity | 98.93% | 19 Sept 2026 | View BPC-157 + TB-500 (Wolverine Stack) lot APL-BPCTB10-2609-04 |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJCIP10-2609-04 | Supplier lab | purity | 99.05% | 19 Sept 2026 | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJCIP10-2609-04 |
| CJC-1295 (No DAC) | APL-CJC10-2609-04 | Supplier lab | purity | 99.09% | 19 Sept 2026 | View CJC-1295 (No DAC) lot APL-CJC10-2609-04 |
| Epitalon | APL-EPI10-2609-02 | Supplier lab | purity | 99.29% | 19 Sept 2026 | View Epitalon lot APL-EPI10-2609-02 |
| GHK-Cu | APL-GHK50-2609-04 | Supplier lab | purity | 99.36% | 19 Sept 2026 | View GHK-Cu lot APL-GHK50-2609-04 |
| Glow Stack | APL-GLOW70-2609-04 | Supplier lab | purity | 99.19% | 19 Sept 2026 | View Glow Stack lot APL-GLOW70-2609-04 |
| Ipamorelin | APL-IPA10-2609-04 | Supplier lab | purity | 99.56% | 19 Sept 2026 | View Ipamorelin lot APL-IPA10-2609-04 |
| Kisspeptin | APL-KISS10-2609-02 | Supplier lab | purity | 99.04% | 19 Sept 2026 | View Kisspeptin lot APL-KISS10-2609-02 |
| KLOW | APL-KLOW80-2609-04 | Supplier lab | purity | 99.38% | 19 Sept 2026 | View KLOW lot APL-KLOW80-2609-04 |
| KPV | APL-KPV10-2609-04 | Supplier lab | purity | 99.79% | 19 Sept 2026 | View KPV lot APL-KPV10-2609-04 |
| MOTS-C | APL-MOTS5-2609-04 | Supplier lab | purity | 98.87% | 19 Sept 2026 | View MOTS-C lot APL-MOTS5-2609-04 |
| NAD+ | APL-NAD500-2609-04 | Supplier lab | purity | 99.32% | 19 Sept 2026 | View NAD+ lot APL-NAD500-2609-04 |
| Retatrutide | APL-RETA5-2609-04 | Supplier lab | purity | 99.29% | 19 Sept 2026 | View Retatrutide lot APL-RETA5-2609-04 |
| Selank | APL-SEL10-2609-04 | Supplier lab | purity | 99.57% | 19 Sept 2026 | View Selank lot APL-SEL10-2609-04 |
| Semax | APL-SEM10-2609-04 | Supplier lab | purity | 99.42% | 19 Sept 2026 | View Semax lot APL-SEM10-2609-04 |
| SS-31 (Elamipretide) | APL-SS3110-2609-02 | Supplier lab | purity | 99.08% | 19 Sept 2026 | View SS-31 (Elamipretide) lot APL-SS3110-2609-02 |
| TB-500 | APL-TB10-2609-04 | Supplier lab | purity | 98.66% | 19 Sept 2026 | View TB-500 lot APL-TB10-2609-04 |
| Tesamorelin | APL-TES10-2609-04 | Supplier lab | purity | 98.7% | 19 Sept 2026 | View Tesamorelin lot APL-TES10-2609-04 |
| Epitalon | APL-EPI10-2608-01 | Supplier lab | purity | 99.41% | 31 Aug 2026 | View Epitalon lot APL-EPI10-2608-01 |
| Kisspeptin | APL-KISS10-2608-01 | Supplier lab | purity | 98.92% | 31 Aug 2026 | View Kisspeptin lot APL-KISS10-2608-01 |
| SS-31 (Elamipretide) | APL-SS3110-2608-01 | Supplier lab | purity | 99.22% | 31 Aug 2026 | View SS-31 (Elamipretide) lot APL-SS3110-2608-01 |
| KPV | APL-KPV10-2608-03 | Supplier lab | purity | 99.66% | 22 Aug 2026 | View KPV lot APL-KPV10-2608-03 |
| CJC-1295 (No DAC) | APL-CJC10-2608-03 | Supplier lab | purity | 98.97% | 20 Aug 2026 | View CJC-1295 (No DAC) lot APL-CJC10-2608-03 |
| Tesamorelin | APL-TES10-2608-03 | Supplier lab | purity | 98.7% | 20 Aug 2026 | View Tesamorelin lot APL-TES10-2608-03 |
| GHK-Cu | APL-GHK50-2608-03 | Supplier lab | purity | 99.49% | 19 Aug 2026 | View GHK-Cu lot APL-GHK50-2608-03 |
| Glow Stack | APL-GLOW70-2608-03 | Supplier lab | purity | 99.24% | 19 Aug 2026 | View Glow Stack lot APL-GLOW70-2608-03 |
| Selank | APL-SEL10-2608-03 | Supplier lab | purity | 99.45% | 19 Aug 2026 | View Selank lot APL-SEL10-2608-03 |
| TB-500 | APL-TB10-2608-03 | Supplier lab | purity | 98.67% | 19 Aug 2026 | View TB-500 lot APL-TB10-2608-03 |
| BPC-157 + TB-500 (Wolverine Stack) | APL-BPCTB10-2608-03 | Supplier lab | purity | 98.89% | 18 Aug 2026 | View BPC-157 + TB-500 (Wolverine Stack) lot APL-BPCTB10-2608-03 |
| Semax | APL-SEM10-2608-03 | Supplier lab | purity | 99.35% | 18 Aug 2026 | View Semax lot APL-SEM10-2608-03 |
| BPC-157 | APL-BPC10-2608-03 | Supplier lab | purity | 99.12% | 17 Aug 2026 | View BPC-157 lot APL-BPC10-2608-03 |
| Ipamorelin | APL-IPA10-2608-03 | Supplier lab | purity | 99.47% | 17 Aug 2026 | View Ipamorelin lot APL-IPA10-2608-03 |
| KLOW | APL-KLOW80-2608-03 | Supplier lab | purity | 99.31% | 17 Aug 2026 | View KLOW lot APL-KLOW80-2608-03 |
| NAD+ | APL-NAD500-2608-03 | Supplier lab | purity | 99.29% | 17 Aug 2026 | View NAD+ lot APL-NAD500-2608-03 |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJCIP10-2608-03 | Supplier lab | purity | 99.08% | 15 Aug 2026 | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJCIP10-2608-03 |
| MOTS-C | APL-MOTS5-2608-03 | Supplier lab | purity | 98.84% | 15 Aug 2026 | View MOTS-C lot APL-MOTS5-2608-03 |
| Retatrutide | APL-RETA5-2608-03 | Supplier lab | purity | 99.31% | 15 Aug 2026 | View Retatrutide lot APL-RETA5-2608-03 |
| MOTS-C | APL-MOTS5-2607-02 | Supplier lab | purity | 99.03% | 22 July 2026 | View MOTS-C lot APL-MOTS5-2607-02 |
| TB-500 | APL-TB10-2607-02 | Supplier lab | purity | 99.21% | 22 July 2026 | View TB-500 lot APL-TB10-2607-02 |
| Retatrutide | APL-RETA5-2607-02 | Supplier lab | purity | 98.77% | 20 July 2026 | View Retatrutide lot APL-RETA5-2607-02 |
| Semax | APL-SEM10-2607-02 | Supplier lab | purity | 98.98% | 20 July 2026 | View Semax lot APL-SEM10-2607-02 |
| CJC-1295 (No DAC) | APL-CJC10-2607-02 | Supplier lab | purity | 98.63% | 19 July 2026 | View CJC-1295 (No DAC) lot APL-CJC10-2607-02 |
| Glow Stack | APL-GLOW70-2607-02 | Supplier lab | purity | 99.07% | 19 July 2026 | View Glow Stack lot APL-GLOW70-2607-02 |
| KPV | APL-KPV10-2607-02 | Supplier lab | purity | 99.11% | 19 July 2026 | View KPV lot APL-KPV10-2607-02 |
| Selank | APL-SEL10-2607-02 | Supplier lab | purity | 99.73% | 18 July 2026 | View Selank lot APL-SEL10-2607-02 |
| Tesamorelin | APL-TES10-2607-02 | Supplier lab | purity | 99.21% | 18 July 2026 | View Tesamorelin lot APL-TES10-2607-02 |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJCIP10-2607-02 | Supplier lab | purity | 99.56% | 17 July 2026 | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJCIP10-2607-02 |
| GHK-Cu | APL-GHK50-2607-02 | Supplier lab | purity | 99.23% | 17 July 2026 | View GHK-Cu lot APL-GHK50-2607-02 |
| Ipamorelin | APL-IPA10-2607-02 | Supplier lab | purity | 99.26% | 17 July 2026 | View Ipamorelin lot APL-IPA10-2607-02 |
| KLOW | APL-KLOW80-2607-02 | Supplier lab | purity | 98.94% | 17 July 2026 | View KLOW lot APL-KLOW80-2607-02 |
| BPC-157 | APL-BPC10-2607-02 | Supplier lab | purity | 99.62% | 15 July 2026 | View BPC-157 lot APL-BPC10-2607-02 |
| BPC-157 + TB-500 (Wolverine Stack) | APL-BPCTB10-2607-02 | Supplier lab | purity | 99.12% | 15 July 2026 | View BPC-157 + TB-500 (Wolverine Stack) lot APL-BPCTB10-2607-02 |
| NAD+ | APL-NAD500-2607-02 | Supplier lab | purity | 99.03% | 15 July 2026 | View NAD+ lot APL-NAD500-2607-02 |
| MOTS-C | APL-MOTS5-2606-01 | Supplier lab | purity | 99.15% | 22 June 2026 | View MOTS-C lot APL-MOTS5-2606-01 |
| TB-500 | APL-TB10-2606-01 | Supplier lab | purity | 98.93% | 22 June 2026 | View TB-500 lot APL-TB10-2606-01 |
| Retatrutide | APL-RETA5-2606-01 | Supplier lab | purity | 99.71% | 20 June 2026 | View Retatrutide lot APL-RETA5-2606-01 |
| Semax | APL-SEM10-2606-01 | Supplier lab | purity | 99.71% | 20 June 2026 | View Semax lot APL-SEM10-2606-01 |
| CJC-1295 (No DAC) | APL-CJC10-2606-01 | Supplier lab | purity | 98.52% | 19 June 2026 | View CJC-1295 (No DAC) lot APL-CJC10-2606-01 |
| Glow Stack | APL-GLOW70-2606-01 | Supplier lab | purity | 99.42% | 19 June 2026 | View Glow Stack lot APL-GLOW70-2606-01 |
| KPV | APL-KPV10-2606-01 | Supplier lab | purity | 99.8% | 19 June 2026 | View KPV lot APL-KPV10-2606-01 |
| Selank | APL-SEL10-2606-01 | Supplier lab | purity | 98.92% | 18 June 2026 | View Selank lot APL-SEL10-2606-01 |
| Tesamorelin | APL-TES10-2606-01 | Supplier lab | purity | 98.98% | 18 June 2026 | View Tesamorelin lot APL-TES10-2606-01 |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJCIP10-2606-01 | Supplier lab | purity | 99.33% | 17 June 2026 | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJCIP10-2606-01 |
| GHK-Cu | APL-GHK50-2606-01 | Supplier lab | purity | 99.68% | 17 June 2026 | View GHK-Cu lot APL-GHK50-2606-01 |
| Ipamorelin | APL-IPA10-2606-01 | Supplier lab | purity | 99.14% | 17 June 2026 | View Ipamorelin lot APL-IPA10-2606-01 |
| KLOW | APL-KLOW80-2606-01 | Supplier lab | purity | 99.18% | 17 June 2026 | View KLOW lot APL-KLOW80-2606-01 |
| BPC-157 | APL-BPC10-2606-01 | Supplier lab | purity | 98.76% | 15 June 2026 | View BPC-157 lot APL-BPC10-2606-01 |
| BPC-157 + TB-500 (Wolverine Stack) | APL-BPCTB10-2606-01 | Supplier lab | purity | 99.26% | 15 June 2026 | View BPC-157 + TB-500 (Wolverine Stack) lot APL-BPCTB10-2606-01 |
| NAD+ | APL-NAD500-2606-01 | Supplier lab | purity | 99.45% | 15 June 2026 | View NAD+ lot APL-NAD500-2606-01 |
| AOD-9604 | — | Janoshik | purity | — | — | View AOD-9604 purity report |
| BPC-157 | APL-BPC10-2608-01 | Ozcanium Analytics | endotoxin | — | — | View BPC-157 lot APL-BPC10-2608-01 |
| BPC-157 | — | Janoshik | purity | — | — | View BPC-157 purity report |
| BPC-157 | — | Ozcanium Analytics | purity | 99.07% | — | View BPC-157 purity report |
| BPC-157 + TB-500 (Wolverine Stack) | — | Ozcanium Analytics | purity | 98.29% | — | View BPC-157 + TB-500 (Wolverine Stack) purity report |
| BPC-157 + TB-500 (Wolverine Stack) | — | Janoshik | purity | — | — | View BPC-157 + TB-500 (Wolverine Stack) purity report |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJC5-2608-01 | Ozcanium Analytics | endotoxin | — | — | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJC5-2608-01 |
| CJC-1295 (No DAC) + Ipamorelin | APL-CJCIP10-2608-01 | Ozcanium Analytics | endotoxin | — | — | View CJC-1295 (No DAC) + Ipamorelin lot APL-CJCIP10-2608-01 |
| CJC-1295 (No DAC) + Ipamorelin | — | Ozcanium Analytics | purity | 99.16% | — | View CJC-1295 (No DAC) + Ipamorelin purity report |
| CJC-1295 (No DAC) + Ipamorelin | — | Ozcanium Analytics | purity | 99.48% | — | View CJC-1295 (No DAC) + Ipamorelin purity report |
| Epitalon | APL-EPI10-2609-01 | Ozcanium Analytics | endotoxin | — | — | View Epitalon lot APL-EPI10-2609-01 |
| Epitalon | — | Ozcanium Analytics | purity | 98.81% | — | View Epitalon purity report |
| GHK-Cu | APL-GHK50-2608-01 | Ozcanium Analytics | endotoxin | — | — | View GHK-Cu lot APL-GHK50-2608-01 |
| GHK-Cu | — | Janoshik | purity | — | — | View GHK-Cu purity report |
| GHK-Cu | — | Janoshik | purity | — | — | View GHK-Cu purity report |
| GHK-Cu | — | Ozcanium Analytics | purity | 99.44% | — | View GHK-Cu purity report |
| Glow Stack | — | Ozcanium Analytics | purity | 99.53% | — | View Glow Stack purity report |
| IGF-1 LR3 | — | Janoshik | purity | — | — | View IGF-1 LR3 purity report |
| Ipamorelin | APL-IPA10-2608-01 | Ozcanium Analytics | endotoxin | — | — | View Ipamorelin lot APL-IPA10-2608-01 |
| Ipamorelin | — | Janoshik | purity | — | — | View Ipamorelin purity report |
| Ipamorelin | — | Ozcanium Analytics | purity | 99.22% | — | View Ipamorelin purity report |
| Kisspeptin | APL-KISS5-2609-01 | Ozcanium Analytics | endotoxin | — | — | View Kisspeptin lot APL-KISS5-2609-01 |
| Kisspeptin | — | Ozcanium Analytics | purity | 98.31% | — | View Kisspeptin purity report |
| KLOW | — | Ozcanium Analytics | purity | 99.4% | — | View KLOW purity report |
| KLOW | — | Janoshik | purity | — | — | View KLOW purity report |
| KPV | — | Ozcanium Analytics | purity | 98.57% | — | View KPV purity report |
| Melanotan II | — | Janoshik | purity | — | — | View Melanotan II purity report |
| MOTS-C | APL-MOTS10-2608-01 | Ozcanium Analytics | endotoxin | — | — | View MOTS-C lot APL-MOTS10-2608-01 |
| MOTS-C | — | Janoshik | purity | — | — | View MOTS-C purity report |
| MOTS-C | — | Ozcanium Analytics | purity | 98.59% | — | View MOTS-C purity report |
| NAD+ | — | Ozcanium Analytics | endotoxin | — | — | View NAD+ endotoxin report |
| Radiance Bundle | — | Janoshik | purity | — | — | View Radiance Bundle purity report |
| Radiance Bundle | — | Janoshik | purity | — | — | View Radiance Bundle purity report |
| Retatrutide | APL-RETA5-2608-01 | Ozcanium Analytics | endotoxin | — | — | View Retatrutide lot APL-RETA5-2608-01 |
| Retatrutide | — | Janoshik | purity | — | — | View Retatrutide purity report |
| Retatrutide | — | — | purity | 99.45% | — | View Retatrutide purity report |
| Retatrutide | — | Janoshik | purity | — | — | View Retatrutide purity report |
| Retatrutide | — | Janoshik | purity | — | — | View Retatrutide purity report |
| Retatrutide | — | Janoshik | purity | — | — | View Retatrutide purity report |
| Retatrutide | — | Janoshik | purity | — | — | View Retatrutide purity report |
| Selank | APL-SEL5-2608-01 | Ozcanium Analytics | endotoxin | — | — | View Selank lot APL-SEL5-2608-01 |
| Selank | — | Janoshik | purity | — | — | View Selank purity report |
| Selank | — | Ozcanium Analytics | purity | 99.17% | — | View Selank purity report |
| Semax | APL-SEM10-2608-01 | Ozcanium Analytics | endotoxin | — | — | View Semax lot APL-SEM10-2608-01 |
| Semax | — | Janoshik | purity | — | — | View Semax purity report |
| Semax | — | Ozcanium Analytics | purity | 99.25% | — | View Semax purity report |
| SS-31 (Elamipretide) | APL-SS3110-2609-01 | Ozcanium Analytics | endotoxin | — | — | View SS-31 (Elamipretide) lot APL-SS3110-2609-01 |
| SS-31 (Elamipretide) | — | Janoshik | purity | — | — | View SS-31 (Elamipretide) purity report |
| SS-31 (Elamipretide) | — | Ozcanium Analytics | purity | 98.89% | — | View SS-31 (Elamipretide) purity report |
| TB-500 | — | Janoshik | purity | — | — | View TB-500 purity report |
| TB-500 | — | Ozcanium Analytics | purity | 98% | — | View TB-500 purity report |
| Tesamorelin | APL-TES5-2608-01 | Ozcanium Analytics | endotoxin | — | — | View Tesamorelin lot APL-TES5-2608-01 |
| Tesamorelin | — | Janoshik | purity | — | — | View Tesamorelin purity report |
| Tesamorelin | — | Ozcanium Analytics | purity | 99.04% | — | View Tesamorelin purity report |